(1 customer review)

Expert In-Company Blended WMO GCP Course for Clinical Trials in the Netherlands

This course was previously called “Blended WMO-GCP training In-Company”. In this mix of self-paced e-learning and a live online training tailor-made to your company’s needs, your team will learn everything they need to know to master ICH-GCP and the WMO law applicable to clinical trials in the Netherlands. Includes 7 interactive e-learning modules and 1 live online training session of 4 hours. The ideal solution for teams.

 375.00

Need more than 5 licenses?

Connect with our corporate team to discuss your organization’s learning needs and discover how our training solutions can help transform your business.

LEARNING OBJECTIVES

  • ICH GCP and ICH GCP R2 Addendum
  • EU Directives (2001 and 2005)
  • Dutch legislation: Medical Research Involving Human Subjects Act (WMO), WGBO and Wet BIG
  • Roles in clinical research
  • Privacy in clinical research (GDPR)
  • Informing research participants
  • Essential documents
  • Review by the Ethics Committee
  • Safety reports and safety of your subjects, incl. AEs, SAEs, and SUSARs
  • Quality management
  • Amendments and derogations
  • Final report
  • Audits and inspections

 

DESCRIPTION

The expert in-company blended GCP course for Clinical Research in the Netherlands is the optimal mix for companies: your team learns about GCP guidelines and Dutch (WMO) legislation online, at their own pace, and apply the GCP and WMO rules to company-specific situations in an instructor-led (virtual) classroom session at your company.

The self-paced online course gives a practical understanding of the ICH GCP guidelines and the Medical Research Involving Human Subjects Act (WMO) in a logical order: from design to the closeout of clinical trials. After completion of the 7 modules of the online course, the attendees have the knowledge to have in-depth discussions at the (virtual) classroom session.

The program of the classroom session is tailored to the needs of the attendees and allows maximum interaction. They are challenged to apply their GCP knowledge to solve company-specific case studies. They will exchange knowledge and experiences with their colleagues and have in-depth discussions with the experienced trainer to maximize their learning experience.

This course is ideal for teams working in the clinical research industry in the Netherlands or experienced staff looking for an extensive update on ICH GCP and WMO.

The completion of the training takes 12 hours, including 8 hours of online learning and a virtual* classroom session of 4 hours. (*We provide virtual classroom training due to corona restrictions)

After the attendees have completed all components of the blended GCP course for clinical research in the Netherlands, they will receive a WMO/GCP Certificate, recognized by Transcelerate and accredited by many quality registers.

All training courses include one-year access to their online training. With our continuous learning model, we will keep your team up-to-date with changing regulations and guidelines.

 

COURSE CONTENTS

[toggles title=”Module:  Introduction”]
You’ll learn the following in this module:

  • Introduction to medical research
  • Types of clinical research (interventional, therapeutic, multi/single center)
  • History of legislation and regulations clinical research (Code of Nuremberg, Declaration of Helsinki)
  • The principles ICH GCP incl. R2 Addendum
  • Laws and regulation clinical research Europe (EU directives 2001 and 2005, EU Regulation 536/2014)
  • Legal framework for clinical research in the Netherlands (WMO, WGBO, Wet BIG, AVG) and scope
  • The roles in clinical research: sponsor, METC, competent authority CCMO or Ministry of Health (VWS), monitor, auditor, researcher, research professional
  • Additional requirements for clinical trials of a medicinal product
  • Phases of a clinical trial of a medicinal product
  • Abbreviations and terminology in medical scientific research

[/toggles]

[toggles title=”Module:  Design”]
You’ll learn the following in this module:

  • Protocol development and content
  • Select research team
  • Selection of investigators and research locations
  • Selection criteria for researchers and research locations
  • Create and store essential documents (Investigator Site File)
  • Risk inventory and assessment
  • Setting up quality assurance: monitoring plan, auditing, DSMB, SOPs

[/toggles]

[toggles title=”Module:  Preparation”]
You’ll learn the following in this module:

  • Package, label, import and deliver a research product
  • Drafting product information (Investigators Brochure, IMPD)
  • Drafting patient information and informed consent with Model Subject Information 2019
  • Contracts and agreements
  • Privacy legislation (AVG)
  • Insurance (subject insurance and liability)

[/toggles]

[toggles title=”Module:  Submission”]
You’ll learn the following in this module:

  • Composition of standard research file
  • Composition and procedure of the review committee (METC or CCMO)
  • Review by an ethical review committee
  • Review by the competent authority: CCMO or Ministry of Health (VWS)
  • Review timelines and submission of amendments
  • Review process and approval
  • Conditions and obligations after approval

[/toggles]

[toggles title=”Module:  Start”]
You’ll learn the following in this module:

  • Delegate tasks and Initiation Visit
  • Supply, storage, and use of the investigational product in a trial
  • Recruitment of subjects
  • Informing subjects
  • Informed Consent procedure
  • Randomization and coding
  • Privacy of data (AVG)
  • Requirements for research with vulnerable subjects

[/toggles]

[toggles title=”Module:  Conduct”]
You’ll learn the following in this module:

  • Amendments, deviations, and changes in protocol and trial
  • Adding new research sites and investigators
  • Safety reports (AE / SAE / SUSAR)
  • Safety subjects medical care and DSMB
  • Documentation and data management (source, CRF, database)
  • Monitoring/ Auditing/ Inspection
  • Quality assurance and risk management (R2 Addendum)
  • Progress reports

[/toggles]

[toggles title=”Module:  Close-Out (Archiving)”]
You’ll learn the following in this module:

  • Regular completion of a trial
  • Preliminary closing of a trial
  • Report end of the trial
  • Requirements for Clinical Study Report
  • Storage and archiving trial documentation
  • Retention deadlines for trial documentation

[/toggles]

[toggles title=”Module: (Virtual) classroom session (tailor-made)”]
You’ll learn the following in this module:

  • Apply GCP knowledge to company-specific situations and case studies
  • Discuss remaining questions with the trainer and colleagues
  • Get detailed insights into topics of interest or specific company policies

[/toggles]

Learn anytime, anywhere

Learn at your own pace on your smartphone, tablet or desktop. You will have one year of access to the training and resources so you can look up information even after you’ve completed the course.

Learn Continiously

Continuous Learning can both improve clinical research quality and ensure a motivated research team. You’ll benefit from better knowledge retention and reduced risks.  We When a regulatory update is announced, we update the training modules and notify you, so that you can take the updated module and earn a new GCP certificate.

Earn your gcp certificate

With our courses, you can earn and maintain your vital industry-recognized certificate. In your GCP Passport, you can now see exactly which version of a training module you were most recently trained on. This documentation in combination with the changelog will inform auditors, managers, and inspectors of the associate’s compliance with current regulations.

1 review for Expert In-Company Blended WMO GCP Course for Clinical Trials in the Netherlands

  1. matyas@igina.net

    One of the best educational experiences that I have ever had.

Add a review

Do you know someone who would like this course? Tell them about it…